Back to results
US 2012/0258477 A1Published application
Fecal neopterin concentration measurement as an indicator of disease activity in inflammatory bowel disease
AssigneeNorthwestern University
InventorAlan L. Buchman
Life of this patent
Estimating the term…
Abstract
Disclosed are methods for determining disease activity in a patient having or at risk for developing inflammatory bowel disease (IBD) which include measuring neopterin concentration in a fecal sample from the patient.
Claims20
A method for determining disease activity in a patient having or at risk for developing inflammatory bowel disease (IBD), the method including measuring neopterin concentration in a fecal sample from the patient.
Dependencies are inferred from the claim text.